Accelerate Diagnostics, Inc. AXDX NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score

18/100

0/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Accelerate Diagnostics, Inc. (AXDX) reported total assets of $28.56M and total liabilities of $84.6M for fiscal year 2024, resulting in total equity of $-56.04M.

The company held $16.3M in cash and short-term investments. Total debt stood at $66.58M, with net debt of $51.48M. The Debt-to-Equity (D/E) ratio was -1.19 (conservative).

Current ratio is 0.71, which may signal tight short-term liquidity. Interest coverage is -2.7x (weak).

Criteria supported by this page:

HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
MOAT (29/100) — Total assets $28.56M and equity $-56.04M support the company's competitive scale

Overall SharesGrow Score: 17/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

18/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

✗

FUTURE

20/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

29/100

→ Income

GROWTH

48/100

→ Income

✗

INCOME

10/100

→ Income

Accelerate Diagnostics, Inc. Balance Sheet History

Metric	FY2024	FY2023	FY2022	FY2021
Total Assets	$28.56M	$31.37M	$65.02M	$83.05M
Total Liabilities	$84.6M	$51.25M	$87.28M	$118.12M
Total Debt	$66.58M	$39.22M	$77.54M	$111.11M
Cash & Investments	$16.3M	$13.22M	$45.56M	$63.62M
Total Stockholders Equity	$-56.04M	$-19.89M	$-22.26M	$-35.07M